CNS Pharmaceuticals, Inc. Short-term Debt
CNS Pharmaceuticals, Inc. (CNSP) had Short-term Debt of $449.87 thousand as of 2022-11-14, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Liabilities, Current › Debt, Current
us-gaap:ShortTermBorrowings · last filed 2023-11-14
- 2022-11-14: Short-term Debt $449.87K.
- 2021-11-08: Short-term Debt $425.99K.
- 2020-12-31: Short-term Debt $482.38K.
| Period end | Short-term Debt |
|---|---|
| 2022-11-14 | $449.87K 10-Q · filed 2023-11-14 |
| 2021-11-08 | $425.99K 10-K · filed 2023-03-31 |
| 2020-12-31 | $482.38K 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |